142 related articles for article (PubMed ID: 30697586)
1. Episodic ataxia in CASPR2 autoimmunity.
López Chiriboga AS; Pittock S
Neurol Neuroimmunol Neuroinflamm; 2019 Mar; 6(2):e536. PubMed ID: 30697586
[No Abstract] [Full Text] [Related]
2. Expanding spectrum of contactin-associated protein 2 (CASPR2) autoimmunity-syndrome of parkinsonism and ataxia.
Kannoth S; Nambiar V; Gopinath S; Anandakuttan A; Mathai A; Rajan PK
Neurol Sci; 2018 Mar; 39(3):455-460. PubMed ID: 29264691
[TBL] [Abstract][Full Text] [Related]
3. Morvan syndrome associated with CASPR2 and LGI1 antibodies in a child.
Nikolaus M; Jackowski-Dohrmann S; Prüss H; Schuelke M; Knierim E
Neurology; 2018 Jan; 90(4):183-185. PubMed ID: 29263225
[No Abstract] [Full Text] [Related]
4. LGI1 and CASPR2 neurological autoimmunity in children.
López-Chiriboga AS; Klein C; Zekeridou A; McKeon A; Dubey D; Flanagan EP; Lennon VA; Tillema JM; Wirrell EC; Patterson MC; Gadoth A; Aaen JG; Brenton JN; Bui JD; Moen A; Otten C; Piquet A; Pittock SJ
Ann Neurol; 2018 Sep; 84(3):473-480. PubMed ID: 30076629
[TBL] [Abstract][Full Text] [Related]
5. Clinical manifestations of patients with CASPR2 antibodies.
Sunwoo JS; Lee ST; Byun JI; Moon J; Shin JW; Jeong DE; Lee GH; Jeong SH; Shin YW; Jung KH; Lee DY; Jeon D; Jung KY; Kim M; Lee SK; Chu K
J Neuroimmunol; 2015 Apr; 281():17-22. PubMed ID: 25867463
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of patients double positive for CASPR2 and LGI1-antibodies.
Jia Y; Shi H; Ye J; Wang Y
Clin Neurol Neurosurg; 2020 Oct; 197():106187. PubMed ID: 32911250
[TBL] [Abstract][Full Text] [Related]
7. The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis.
van Sonderen A; Petit-Pedrol M; Dalmau J; Titulaer MJ
Nat Rev Neurol; 2017 May; 13(5):290-301. PubMed ID: 28418022
[TBL] [Abstract][Full Text] [Related]
8. The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies.
van Sonderen A; Schreurs MW; de Bruijn MA; Boukhrissi S; Nagtzaam MM; Hulsenboom ES; Enting RH; Thijs RD; Wirtz PW; Sillevis Smitt PA; Titulaer MJ
Neurology; 2016 May; 86(18):1692-9. PubMed ID: 27037230
[TBL] [Abstract][Full Text] [Related]
9. Distinction between anti-VGKC-complex seropositive patients with and without anti-LGI1/CASPR2 antibodies.
Yeo T; Chen Z; Yong KP; Wong PYW; Chai JYH; Tan K
J Neurol Sci; 2018 Aug; 391():64-71. PubMed ID: 30103974
[TBL] [Abstract][Full Text] [Related]
10. LGI1 and CASPR2 autoimmunity in children: Systematic literature review and report of a young girl with Morvan syndrome.
Nosadini M; Toldo I; Tascini B; Bien CG; Parmeggiani L; De Gaspari P; Zuliani L; Sartori S
J Neuroimmunol; 2019 Oct; 335():577008. PubMed ID: 31352183
[TBL] [Abstract][Full Text] [Related]
11. Daratumumab treatment for therapy-refractory anti-CASPR2 encephalitis.
Scheibe F; Ostendorf L; Reincke SM; Prüss H; von Brünneck AC; Köhnlein M; Alexander T; Meisel C; Meisel A
J Neurol; 2020 Feb; 267(2):317-323. PubMed ID: 31630242
[TBL] [Abstract][Full Text] [Related]
12. Chronic ataxic neuropathy with cold agglutinins: atypical phenotype and response to anti-CD20 antibodies.
Siddiqui K; Cahalane E; Keogan M; Hardiman O
Neurology; 2003 Nov; 61(9):1307-8. PubMed ID: 14610153
[No Abstract] [Full Text] [Related]
13. Overinterpretation and Overtreatment of Low-Titer Antibodies Against Contactin-Associated Protein-2.
Bien CG
Front Immunol; 2018; 9():703. PubMed ID: 29696018
[TBL] [Abstract][Full Text] [Related]
14. Detection of LGI1 and CASPR2 antibodies with a commercial cell-based assay in patients with very high VGKC-complex antibody levels.
Yeo T; Chen Z; Chai JYH; Tan K
J Neurol Sci; 2017 Jul; 378():85-90. PubMed ID: 28566186
[TBL] [Abstract][Full Text] [Related]
15. [Neuroimmunological diseases associated with VGKC complex antibodies].
Watanabe O
Nihon Rinsho; 2013 May; 71(5):915-20. PubMed ID: 23777104
[TBL] [Abstract][Full Text] [Related]
16. Monosialosyl Antibody in a Case Mimicking CANOMAD Syndrome.
Oh SJ; Almeida DF; Villa SC
J Clin Neuromuscul Dis; 2019 Sep; 21(1):53-54. PubMed ID: 31453857
[No Abstract] [Full Text] [Related]
17. CASPR2 autoimmunity in children expanding to mild encephalopathy with hypertension.
Syrbe S; Stettner GM; Bally J; Borggraefe I; Bien CI; Ferfoglia RI; Huppke P; Kern J; Polster T; Probst-Müller E; Schmid S; Steinfeld R; Strozzi S; Weichselbaum A; Weitz M; Ziegler A; Wandinger KP; Leypoldt F; Bien CG
Neurology; 2020 Jun; 94(22):e2290-e2301. PubMed ID: 32424051
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune Neurological Disorder with Anti-Ma2/Ta Antibodies in a Pediatric Patient.
Boniel S; Jeziorek A; Woźniak M; Lipińska E; Szczepanik E; Demkow U; Szymańska K
Isr Med Assoc J; 2018 Oct; 20(10):653-655. PubMed ID: 30324788
[No Abstract] [Full Text] [Related]
19. Glutamic acid decarboxylase autoimmunity in Batten disease and other disorders.
Pearce DA; Atkinson M; Tagle DA
Neurology; 2004 Dec; 63(11):2001-5. PubMed ID: 15596740
[TBL] [Abstract][Full Text] [Related]
20. Anti-contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation and outcome.
Bien CG; Mirzadjanova Z; Baumgartner C; Onugoren MD; Grunwald T; Holtkamp M; Isenmann S; Kermer P; Melzer N; Naumann M; Riepe M; Schäbitz WR; von Oertzen TJ; von Podewils F; Rauschka H; May TW
Eur J Neurol; 2017 Jan; 24(1):175-186. PubMed ID: 27786401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
